Some researchers have obtained ovary tissue from patients with ovarian insufficiency for IVA that involves Hippo signalling disruption and protein kinase B (AKT) stimulation, followed by auto-transplantation and assisted reproductive technologies. The gene discussed is AKT1; the disease is ovarian dysfunction.